检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

OA01.07 A Phase II Study of the Oral Selective AXL Inhibitor Bemcentinib with Pembrolizumab in Patients with Advanced NSCLC

M.G. Krebs,Å. Helland,E. Carcereny Costa,E. Arriola Aperribay,M. Dómine Gómez,J. Trigo Pérez,J. Thompson,J. Strauss,A.L. Ortega Granados, E. Felip,E. Schmidt, M. Chisamore, N. Madeleine, A. Rayford, K. Lorens, A. Siddiqui,H. Gabra, J. Nautiyal,D. Micklem,J. Lorens, J. Spicer

Journal of Thoracic Oncology（2021）

引用 1|浏览6
暂无评分
关键词
bemcentinib, immunotherapy rechallenge, AXL
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要